Cost-effectiveness analysis of CAR-T therapy

Papers Unplugged: Is CAR-T Economically Sustainable?Подробнее

The value of axi-cel as a second-line treatment in R/R LBCLПодробнее

The cost-effectiveness of CAR T-cell therapyПодробнее

Revolutionizing Cancer Care: Affordable CAR-T Therapy by IIT Bombay | NeosciencehubПодробнее

06 Memory-rich CAR-T cell engineering by piggyBac transposon system for solid malignanciesПодробнее

Progress Report IV - Ádám SzilágyiПодробнее

Evaluating the cost and benefits of CAR-T therapyПодробнее

Economic burden of CAR-T therapy from a UK perspectiveПодробнее

CAR-T Cell Pricing Strategy by Saif Alshagra EMBA134Подробнее

Role of CD19 CAR T Cells in Second Line Large B Cell LymphomaПодробнее

Cost-effectiveness of brexu-cel in adult patients with R/R ALL in the USПодробнее

Distributional cost-effectiveness analysis of gene therapy vs SOC in patients with SCD in the USПодробнее

[lymphoma] After Polatuzumab and CAR-T appeared, Lymphoma Treatment Cost ConcernsПодробнее

What Questions are Current Myeloma Trials NOT Answering | Invited Talk to UK Myeloma Research DayПодробнее

G-Rex: Revolutionizing T Cell TherapyПодробнее

Summit Speaker Series: Developing better CAR T-Cell TherapiesПодробнее

Cost-effectiveness of CAR T-cell therapyПодробнее

Webinar: RWE, CAR-T and Cancer – New Methods for Comparative EffectivenessПодробнее

Cost-effective lymphoma treatment for developing countriesПодробнее

CAR T-cell therapy economics in the real worldПодробнее